Human Organoids Market by Product (Pancreas, Kidney, Lung, GIT, Liver Models) Usabilty (Customized, Ready-To-Use), Application (Toxicity, Pathology, Personalized & Regenerative Medicine), Enduser (Pharma-Biotech, CROs, Academia) - Global Forecast to 2025
The global human organoids market size is projected to reach USD 1,901 million by 2025 from USD 850 million in 2020, at a CAGR of 17.5%. Factors such as the technological advancements in the market are propelling the growth of the human orgnaoids market. Additionally, rising cases of transplants, investments from both private and public sectors are having affect in the growth of human organoids market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of this market.
The recent COVID-19 global pandemic has also impacted the human organoids market. Demand from the main end-users has declined as key regions and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.
“The kidney segment to witness the highest growth rate in human organoids market, by product, during the forecast period.”
The kidney segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of kidney diseases across major markets (resulting in a growing number of transplants procedures), the growing trend of increasing purchasing power of people, especially across emerging countries.
“The developmental biology accounted for the largest share of the human orgnaoids market, by human organoids, in 2020.”
The developmental biology segment accounted for the largest share of the human orgnaoids market in 2020. Technological advancements in the field of 3D bioprinting have shown huge potential for organ development as the culture time is very less compared to traditional methods of tissue culture. Patient-derived human organoid studies may accelerate medical research, creating new opportunities for tissue engineering and regenerative medicine and generating knowledge and tools for preclinical studies, including drug development and testing.
“The pharmaceuticals & biotechnology companies segment accounted for the largest share of the human organoids, by end users, in 2020”
Pharmaceutical and biotechnology companies mainly focus on developing new drugs for the treatment of various rare diseases. These companies need to submit specific data related to drug development during the drug development process and subsequent filing of applications to regulatory bodies. This necessitates a wide spectrum of services in the early development phases and clinical phases to comply with regulatory requirements.
“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The clinical microbiology market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increase awareness related to human orgnaoids, supportive regulations for the development and commercialization of advanced human organoids products, rising healthcare expenditure, increasing number of hospitals and clinics in India and China, expanding research base across India, China, and Japan, and the increasing incidence of transplants are the major factors driving the growth of the APAC human organoids market.
Breakdown of supply-side primary interviews:
Research Coverage
This report studies the human organoids market based on the product, application, usabilty, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the human organoids market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
The recent COVID-19 global pandemic has also impacted the human organoids market. Demand from the main end-users has declined as key regions and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.
“The kidney segment to witness the highest growth rate in human organoids market, by product, during the forecast period.”
The kidney segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of kidney diseases across major markets (resulting in a growing number of transplants procedures), the growing trend of increasing purchasing power of people, especially across emerging countries.
“The developmental biology accounted for the largest share of the human orgnaoids market, by human organoids, in 2020.”
The developmental biology segment accounted for the largest share of the human orgnaoids market in 2020. Technological advancements in the field of 3D bioprinting have shown huge potential for organ development as the culture time is very less compared to traditional methods of tissue culture. Patient-derived human organoid studies may accelerate medical research, creating new opportunities for tissue engineering and regenerative medicine and generating knowledge and tools for preclinical studies, including drug development and testing.
“The pharmaceuticals & biotechnology companies segment accounted for the largest share of the human organoids, by end users, in 2020”
Pharmaceutical and biotechnology companies mainly focus on developing new drugs for the treatment of various rare diseases. These companies need to submit specific data related to drug development during the drug development process and subsequent filing of applications to regulatory bodies. This necessitates a wide spectrum of services in the early development phases and clinical phases to comply with regulatory requirements.
“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The clinical microbiology market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increase awareness related to human orgnaoids, supportive regulations for the development and commercialization of advanced human organoids products, rising healthcare expenditure, increasing number of hospitals and clinics in India and China, expanding research base across India, China, and Japan, and the increasing incidence of transplants are the major factors driving the growth of the APAC human organoids market.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
- By Designation: C-level: 30%, D-level: 29%, and Others: 47%
- By Region: North America: 40%, Europe: 30%, APAC: 22%, Latin America: 6%, and the Middle East & Africa: 2%
Research Coverage
This report studies the human organoids market based on the product, application, usabilty, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the human organoids market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: HUMAN ORGANOIDS MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PROCEDURE-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: HUMAN ORGANOIDS MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 6 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 8 HUMAN ORGANOIDS MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE HUMAN ORGANOIDS MARKET
4 PREMIUM INSIGHTS
4.1 HUMAN ORGANOIDS MARKET OVERVIEW
FIGURE 10 GROWING FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING MODELS TO DRIVE MARKET GROWTH
4.2 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 11 LIVER ORGANOIDS ARE EXPECTED TO DOMINATE THE HUMAN ORGANOID PRODUCTS MARKET
4.3 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY END USER & COUNTRY (2019)
FIGURE 12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC HUMAN ORGANOIDS MARKET IN 2019
4.4 GEOGRAPHIC ANALYSIS: HUMAN ORGANOIDS MARKET, BY USABILITY (2019)
FIGURE 13 READY-TO-USE PRODUCTS SEGMENT DOMINATES THE GLOBAL HUMAN ORGANOIDS MARKET
4.5 HUMAN ORGANOIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 HUMAN ORGANOIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing focus on developing alternatives for animal testing models
5.2.1.2 Significant increase in research funding and venture capital investments for the development of human organoids
5.2.1.3 Growing initiatives to increase awareness about organoids
TABLE 2 GROWING INITIATIVES AND EVENTS FOR ORGANOIDS
5.2.1.4 Increasing research activities on organoids
TABLE 3 RESEARCH PROJECTS AND ACTIVITIES
5.2.1.5 Increasing prevalence of non-alcoholic fatty liver disease
5.2.1.6 Growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure
5.2.2 RESTRAINTS
5.2.2.1 Issues related to the incorporation of organoids into existing workflows
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing focus on drug discovery activities
5.2.3.2 Rising demand for organ transplantation
5.2.3.3 Growing healthcare market in the Asia Pacific and Latin America
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE HUMAN ORGANOIDS MARKET
5.4 REGULATORY SCENARIO
5.5 ECOSYSTEM COVERAGE
5.6 TECHNOLOGY ANALYSIS
5.7 PRICING ANALYSIS
6 HUMAN ORGANOIDS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 4 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
6.2 LIVER
TABLE 5 HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.2.1 2D LIVER MODELS
TABLE 6 2D LIVER MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.2.1.1 Fresh hepatocytes
TABLE 7 FRESH HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.1.2 Cryopreserved hepatocytes
TABLE 8 CRYOPRESERVED HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.1.3 Other 2D liver models
TABLE 9 OTHER 2D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2 3D LIVER MODELS
TABLE 10 3D LIVER MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 11 3D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.1 Liver organoids
TABLE 12 LIVER ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.2 3D bioprinted liver
TABLE 13 3D BIOPRINTED LIVER MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.3 Spheroids
TABLE 14 LIVER SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.4 Liver-on-a-chip
TABLE 15 LIVER-ON-A-CHIP MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.5 Other 3D liver models
TABLE 16 OTHER 3D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3 KIDNEY
TABLE 17 HUMAN KIDNEY ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.3.1 2D KIDNEY MODELS
TABLE 18 2D KIDNEY MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.3.1.1 Fresh kidney cells
TABLE 19 FRESH KIDNEY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.1.2 Cryopreserved cells
TABLE 20 KIDNEY CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.1.3 Other 2D kidney models
TABLE 21 OTHER 2D KIDNEY MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2 3D KIDNEY MODELS
TABLE 22 3D KIDNEY MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 23 3D KIDNEY MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.1 Organoids
TABLE 24 KIDNEY ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.2 3D bioprinted kidney
TABLE 25 3D BIOPRINTED KIDNEY MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.3 Spheroids
TABLE 26 KIDNEY SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.4 Other 3D kidney models
TABLE 27 OTHER 3D KIDNEY MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4 PANCREAS
TABLE 28 HUMAN PANCREAS ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.4.1 2D PANCREATIC MODELS
TABLE 29 2D PANCREATIC MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.4.1.1 Cryopreserved cells
TABLE 30 PANCREATIC CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.1.2 Fresh cells
TABLE 31 PANCRATIC FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.1.3 Other 2D pancreatic models
TABLE 32 OTHER 2D PANCREATIC MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2 3D PANCREATIC MODELS
TABLE 33 3D PANCREATIC MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 34 3D PANCREATIC MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.1 Organoids
TABLE 35 PANCREATIC ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.2 3D bioprinted pancreas
TABLE 36 3D BIOPRINTED PANCREAS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.3 Spheroids
TABLE 37 PANCREATIC SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.4 Other 3D pancreatic models
TABLE 38 OTHER 3D PANCREATIC MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5 COLORECTAL
TABLE 39 HUMAN COLORECTAL ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.5.1 2D COLORECTAL MODELS
TABLE 40 2D COLORECTAL MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.5.1.1 Fresh cells
TABLE 41 COLORECTAL FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.1.2 Cryopreserved cells
TABLE 42 COLORECTAL CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.1.3 Other 2D colorectal models
TABLE 43 OTHER 2D COLORECTAL MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2 3D COLORECTAL MODELS
TABLE 44 3D COLORECTAL MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 45 3D COLORECTAL MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.1 Organoids
TABLE 46 COLORECTAL ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.2 3D bioprinted models
TABLE 47 COLORECTAL 3D BIOPRINTED MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.3 Spheroids
TABLE 48 COLORECTAL SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.4 Other 3D colorectal models
TABLE 49 OTHER 3D COLORECTAL MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6 HEART
TABLE 50 HUMAN HEART ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.6.1 2D HEART MODELS
TABLE 51 2D HEART MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.6.1.1 Fresh cells
TABLE 52 HEART FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.1.2 Cryopreserved cells
TABLE 53 HEART CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.1.3 Other 2D heart models
TABLE 54 OTHER 2D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2 3D HEART MODELS
TABLE 55 3D HEART MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 56 3D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.1 Organoids
TABLE 57 HEART ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.2 3D bioprinted heart
TABLE 58 3D BIOPRINTED HEART MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.3 Spheroids
TABLE 59 HEART SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.4 Other 3D heart models
TABLE 60 OTHER 3D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7 OTHER PRODUCTS
TABLE 61 HUMAN ORGANOIDS MARKET FOR OTHER PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
6.7.1 2D MODELS
TABLE 62 OTHERS 2D MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.7.1.1 Fresh cells
TABLE 63 OTHERS FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.1.2 Cryopreserved cells
TABLE 64 OTHERS CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.1.3 Other 2D models
TABLE 65 OTHERS OTHER 2D MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2 3D MODELS
TABLE 66 OTHERS 3D MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 67 3D OTHER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.1 Organoids
TABLE 68 OTHERS ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.2 3D bioprinted models
TABLE 69 OTHERS 3D BIOPRINTED MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.3 Spheroids
TABLE 70 OTHERS SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.4 Other 3D models
TABLE 71 OTHERS OTHER 3D MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
7 HUMAN ORGANOIDS MARKET, BY USABILITY
7.1 INTRODUCTION
TABLE 72 HUMAN ORGANOIDS MARKET, BY USABILITY, 2018-2025 (USD MILLION)
7.2 READY-TO-USE PRODUCTS
7.2.1 READY-TO-USE PRODUCTS SEGMENT TO DOMINATE THE MARKET AS THEY CAN BE MASS PRODUCED
TABLE 73 HUMAN ORGANOIDS MARKET FOR READY-TO-USE PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
7.3 CUSTOMIZABLE PRODUCTS
7.3.1 CUSTOMIZABLE PRODUCTS CAN FULFIL THE REQUIREMENT FOR A SPECIFIC NEED OF ORGAN TRANSPLANTATION
TABLE 74 HUMAN ORGANOIDS MARKET FOR CUSTOMIZABLE PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
8 HUMAN ORGANOIDS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 75 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
8.2 DEVELOPMENTAL BIOLOGY
8.2.1 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF 3D BIOPRINTING WILL BOOST MARKET GROWTH
TABLE 76 HUMAN ORGANOIDS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2025 (USD MILLION)
8.3 DRUG TOXICITY & EFFICACY TESTING
8.3.1 DRUG TOXICITY & EFFICACY TESTING WILL WITNESS GROWTH AS ORGANOIDS SHOW HIGH RESISTANCE TOWARDS CLINICAL DOSES
TABLE 77 HUMAN ORGANOIDS MARKET FOR DRUG TOXICITY & EFFICACY TESTING, BY REGION, 2018-2025 (USD MILLION)
8.4 DISEASE PATHOLOGY
8.4.1 DEVELOPMENT OF INTESTINAL ORGANOIDS TO SUPPORT MARKET GROWTH
TABLE 78 HUMAN ORGANOIDS MARKET FOR DISEASE PATHOLOGY, BY REGION, 2018-2025 (USD MILLION)
8.5 PERSONALIZED MEDICINE
8.5.1 HIGH COST OF DEVELOPING ORGANOIDS TO HAMPER MARKET GROWTH
TABLE 79 HUMAN ORGANOIDS MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2018-2025 (USD MILLION)
8.6 REGENERATIVE MEDICINE
8.6.1 ORGANOIDS HOLD A HUGE POTENTIAL IN REGENERATIVE MEDICINE PURPOSES
TABLE 80 HUMAN ORGANOIDS MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2018-2025 (USD MILLION)
8.7 OTHER APPLICATIONS
TABLE 81 HUMAN ORGANOIDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
9 HUMAN ORGANOIDS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 82 HUMAN ORGANOIDS MARKET, BY END USER, 2018-2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF HUMAN ORGANOID PRODUCTS
TABLE 83 HUMAN ORGANOIDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.3.1 INCREASING OUTSOURCING OF CLINICAL RESEARCH SERVICES BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH
TABLE 84 HUMAN ORGANOIDS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 HIGH COST OF TECHNOLOGICALLY ADVANCED ORGANOIDS IS EXPECTED TO HAMPER MARKET GROWTH FOR THESE FACILITIES
TABLE 85 HUMAN ORGANOIDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
9.5 OTHER END USERS
TABLE 86 HUMAN ORGANOIDS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
10 HUMAN ORGANOIDS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 87 HUMAN ORGANOIDS MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 16 NORTH AMERICA: HUMAN ORGANOIDS MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 93 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 94 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 Ongoing technological advancements in the field of transplantation to drive market growth in the US
TABLE 95 US: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Growing availability of human organoid products to support market growth in Canada
TABLE 96 CANADA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 97 EUROPE: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 EUROPE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 EUROPE: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 EUROPE: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 EUROPE: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 102 EUROPE: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 103 EUROPE: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany dominates the European human organoids market
TABLE 104 GERMANY: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising number of transplantation procedures to drive market growth in the UK
TABLE 105 UK: NUMBER OF TRANSPLANTATION PROCEDURES, BY ORGAN TYPE, 2018
TABLE 106 UK: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Adoption of molecular diagnostic techniques for donor-recipient compatibility testing is increasing in France
TABLE 107 FRANCE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Sluggish growth in the Italian healthcare sector to restrain the market growth
TABLE 108 ITALY: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising number of solid organ transplantation procedures to drive market growth in Spain
TABLE 109 SPAIN: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 110 ROE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 17 ASIA PACIFIC: HUMAN ORGANOIDS MARKET SNAPSHOT
TABLE 111 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 117 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Growth in biomedical & medical research to support market growth
TABLE 118 JAPAN: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Healthcare infrastructure improvements to support market growth in China
TABLE 119 CHINA: NUMBER OF ORGAN TRANSPLANTATION PROCEDURES PERFORMED, 2018
TABLE 120 CHINA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing number of transplantation procedures to drive market growth in India
TABLE 121 INDIA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Rising number of solid organ transplantation procedures to support market growth in Australia
TABLE 122 AUSTRALIA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Government initiatives to introduce medical coverage for transplantation to support market growth in South Korea
TABLE 123 SOUTH KOREA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 124 ROAPAC: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5 LATIN AMERICA
TABLE 125 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 126 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 130 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 131 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil is the largest market for human organoids in Latin America
TABLE 132 BRAZIL: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Rising medical tourism to support market growth in Mexico
TABLE 133 MEXICO: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 134 ROLATAM: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
TABLE 135 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 18 KEY DEVELOPMENTS IN THE HUMAN ORGANOIDS MARKET, 2017–2020
11.2 MARKET SHARE ANALYSIS
FIGURE 19 HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2019
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES
TABLE 141 PRODUCT LAUNCH, 2017-2020
11.3.2 AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS
TABLE 142 AGREEMENTS, COLLABORATIONS & PARTNERSHIP, 2017-2020
11.3.3 MERGERS
TABLE 143 MERGERS, 2018
12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES
12.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
12.1.1 STARS
12.1.2 EMERGING LEADERS
12.1.3 PERVASIVE
12.1.4 PARTICIPANTS
FIGURE 20 HUMAN ORGANOIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
12.2 COMPANY PROFILES
(Business overview, Products offered & Recent developments)*
12.2.1 BIOIVT
12.2.2 CELLINK
FIGURE 21 CELLINK: COMPANY SNAPSHOT
12.2.3 CORNING INCORPORATED
FIGURE 22 CORNING INCORPORATED: COMPANY SNAPSHOT
12.2.4 CYTES BIOTECHNOLOGIES, S.L.
12.2.5 HµREL CORPORATION
12.2.6 INSPHERO
12.2.7 KALY-CELL
12.2.8 KIRKSTALL LTD.
12.2.9 MIMETAS B.V.
12.2.10 NEUROMICS
12.2.11 ORGANOVO
12.2.12 PRIMACYT CELL CULTURE TECHNOLOGY GMBH
12.2.13 STEMCELL TECHNOLOGIES INC.
12.2.14 THERMO FISHER SCIENTIFIC
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
12.2.15 ZENBIO, INC.
*Details on Business overview, Products offered & Recent developments might not be captured in case of unlisted companies.
12.3 EMERGING COMPANIES
12.3.1 BIOPREDIC INTERNATIONAL
12.3.2 CN BIO INNOVATIONS
12.3.3 CYPRIO
12.3.4 EMULATE, INC.
12.3.5 KERAFAST
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: HUMAN ORGANOIDS MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PROCEDURE-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: HUMAN ORGANOIDS MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 6 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 8 HUMAN ORGANOIDS MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE HUMAN ORGANOIDS MARKET
4 PREMIUM INSIGHTS
4.1 HUMAN ORGANOIDS MARKET OVERVIEW
FIGURE 10 GROWING FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING MODELS TO DRIVE MARKET GROWTH
4.2 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 11 LIVER ORGANOIDS ARE EXPECTED TO DOMINATE THE HUMAN ORGANOID PRODUCTS MARKET
4.3 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY END USER & COUNTRY (2019)
FIGURE 12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC HUMAN ORGANOIDS MARKET IN 2019
4.4 GEOGRAPHIC ANALYSIS: HUMAN ORGANOIDS MARKET, BY USABILITY (2019)
FIGURE 13 READY-TO-USE PRODUCTS SEGMENT DOMINATES THE GLOBAL HUMAN ORGANOIDS MARKET
4.5 HUMAN ORGANOIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 HUMAN ORGANOIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing focus on developing alternatives for animal testing models
5.2.1.2 Significant increase in research funding and venture capital investments for the development of human organoids
5.2.1.3 Growing initiatives to increase awareness about organoids
TABLE 2 GROWING INITIATIVES AND EVENTS FOR ORGANOIDS
5.2.1.4 Increasing research activities on organoids
TABLE 3 RESEARCH PROJECTS AND ACTIVITIES
5.2.1.5 Increasing prevalence of non-alcoholic fatty liver disease
5.2.1.6 Growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure
5.2.2 RESTRAINTS
5.2.2.1 Issues related to the incorporation of organoids into existing workflows
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing focus on drug discovery activities
5.2.3.2 Rising demand for organ transplantation
5.2.3.3 Growing healthcare market in the Asia Pacific and Latin America
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE HUMAN ORGANOIDS MARKET
5.4 REGULATORY SCENARIO
5.5 ECOSYSTEM COVERAGE
5.6 TECHNOLOGY ANALYSIS
5.7 PRICING ANALYSIS
6 HUMAN ORGANOIDS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 4 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
6.2 LIVER
TABLE 5 HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.2.1 2D LIVER MODELS
TABLE 6 2D LIVER MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.2.1.1 Fresh hepatocytes
TABLE 7 FRESH HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.1.2 Cryopreserved hepatocytes
TABLE 8 CRYOPRESERVED HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.1.3 Other 2D liver models
TABLE 9 OTHER 2D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2 3D LIVER MODELS
TABLE 10 3D LIVER MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 11 3D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.1 Liver organoids
TABLE 12 LIVER ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.2 3D bioprinted liver
TABLE 13 3D BIOPRINTED LIVER MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.3 Spheroids
TABLE 14 LIVER SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.4 Liver-on-a-chip
TABLE 15 LIVER-ON-A-CHIP MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2.5 Other 3D liver models
TABLE 16 OTHER 3D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3 KIDNEY
TABLE 17 HUMAN KIDNEY ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.3.1 2D KIDNEY MODELS
TABLE 18 2D KIDNEY MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.3.1.1 Fresh kidney cells
TABLE 19 FRESH KIDNEY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.1.2 Cryopreserved cells
TABLE 20 KIDNEY CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.1.3 Other 2D kidney models
TABLE 21 OTHER 2D KIDNEY MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2 3D KIDNEY MODELS
TABLE 22 3D KIDNEY MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 23 3D KIDNEY MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.1 Organoids
TABLE 24 KIDNEY ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.2 3D bioprinted kidney
TABLE 25 3D BIOPRINTED KIDNEY MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.3 Spheroids
TABLE 26 KIDNEY SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.4 Other 3D kidney models
TABLE 27 OTHER 3D KIDNEY MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4 PANCREAS
TABLE 28 HUMAN PANCREAS ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.4.1 2D PANCREATIC MODELS
TABLE 29 2D PANCREATIC MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.4.1.1 Cryopreserved cells
TABLE 30 PANCREATIC CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.1.2 Fresh cells
TABLE 31 PANCRATIC FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.1.3 Other 2D pancreatic models
TABLE 32 OTHER 2D PANCREATIC MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2 3D PANCREATIC MODELS
TABLE 33 3D PANCREATIC MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 34 3D PANCREATIC MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.1 Organoids
TABLE 35 PANCREATIC ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.2 3D bioprinted pancreas
TABLE 36 3D BIOPRINTED PANCREAS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.3 Spheroids
TABLE 37 PANCREATIC SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2.4 Other 3D pancreatic models
TABLE 38 OTHER 3D PANCREATIC MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5 COLORECTAL
TABLE 39 HUMAN COLORECTAL ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.5.1 2D COLORECTAL MODELS
TABLE 40 2D COLORECTAL MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.5.1.1 Fresh cells
TABLE 41 COLORECTAL FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.1.2 Cryopreserved cells
TABLE 42 COLORECTAL CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.1.3 Other 2D colorectal models
TABLE 43 OTHER 2D COLORECTAL MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2 3D COLORECTAL MODELS
TABLE 44 3D COLORECTAL MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 45 3D COLORECTAL MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.1 Organoids
TABLE 46 COLORECTAL ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.2 3D bioprinted models
TABLE 47 COLORECTAL 3D BIOPRINTED MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.3 Spheroids
TABLE 48 COLORECTAL SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2.4 Other 3D colorectal models
TABLE 49 OTHER 3D COLORECTAL MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6 HEART
TABLE 50 HUMAN HEART ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.6.1 2D HEART MODELS
TABLE 51 2D HEART MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.6.1.1 Fresh cells
TABLE 52 HEART FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.1.2 Cryopreserved cells
TABLE 53 HEART CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.1.3 Other 2D heart models
TABLE 54 OTHER 2D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2 3D HEART MODELS
TABLE 55 3D HEART MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 56 3D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.1 Organoids
TABLE 57 HEART ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.2 3D bioprinted heart
TABLE 58 3D BIOPRINTED HEART MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.3 Spheroids
TABLE 59 HEART SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.6.2.4 Other 3D heart models
TABLE 60 OTHER 3D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7 OTHER PRODUCTS
TABLE 61 HUMAN ORGANOIDS MARKET FOR OTHER PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
6.7.1 2D MODELS
TABLE 62 OTHERS 2D MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.7.1.1 Fresh cells
TABLE 63 OTHERS FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.1.2 Cryopreserved cells
TABLE 64 OTHERS CRYOPRESERVED CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.1.3 Other 2D models
TABLE 65 OTHERS OTHER 2D MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2 3D MODELS
TABLE 66 OTHERS 3D MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 67 3D OTHER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.1 Organoids
TABLE 68 OTHERS ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.2 3D bioprinted models
TABLE 69 OTHERS 3D BIOPRINTED MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.3 Spheroids
TABLE 70 OTHERS SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.7.2.4 Other 3D models
TABLE 71 OTHERS OTHER 3D MODELS MARKET, BY REGION, 2018-2025 (USD MILLION)
7 HUMAN ORGANOIDS MARKET, BY USABILITY
7.1 INTRODUCTION
TABLE 72 HUMAN ORGANOIDS MARKET, BY USABILITY, 2018-2025 (USD MILLION)
7.2 READY-TO-USE PRODUCTS
7.2.1 READY-TO-USE PRODUCTS SEGMENT TO DOMINATE THE MARKET AS THEY CAN BE MASS PRODUCED
TABLE 73 HUMAN ORGANOIDS MARKET FOR READY-TO-USE PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
7.3 CUSTOMIZABLE PRODUCTS
7.3.1 CUSTOMIZABLE PRODUCTS CAN FULFIL THE REQUIREMENT FOR A SPECIFIC NEED OF ORGAN TRANSPLANTATION
TABLE 74 HUMAN ORGANOIDS MARKET FOR CUSTOMIZABLE PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
8 HUMAN ORGANOIDS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 75 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
8.2 DEVELOPMENTAL BIOLOGY
8.2.1 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF 3D BIOPRINTING WILL BOOST MARKET GROWTH
TABLE 76 HUMAN ORGANOIDS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2025 (USD MILLION)
8.3 DRUG TOXICITY & EFFICACY TESTING
8.3.1 DRUG TOXICITY & EFFICACY TESTING WILL WITNESS GROWTH AS ORGANOIDS SHOW HIGH RESISTANCE TOWARDS CLINICAL DOSES
TABLE 77 HUMAN ORGANOIDS MARKET FOR DRUG TOXICITY & EFFICACY TESTING, BY REGION, 2018-2025 (USD MILLION)
8.4 DISEASE PATHOLOGY
8.4.1 DEVELOPMENT OF INTESTINAL ORGANOIDS TO SUPPORT MARKET GROWTH
TABLE 78 HUMAN ORGANOIDS MARKET FOR DISEASE PATHOLOGY, BY REGION, 2018-2025 (USD MILLION)
8.5 PERSONALIZED MEDICINE
8.5.1 HIGH COST OF DEVELOPING ORGANOIDS TO HAMPER MARKET GROWTH
TABLE 79 HUMAN ORGANOIDS MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2018-2025 (USD MILLION)
8.6 REGENERATIVE MEDICINE
8.6.1 ORGANOIDS HOLD A HUGE POTENTIAL IN REGENERATIVE MEDICINE PURPOSES
TABLE 80 HUMAN ORGANOIDS MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2018-2025 (USD MILLION)
8.7 OTHER APPLICATIONS
TABLE 81 HUMAN ORGANOIDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
9 HUMAN ORGANOIDS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 82 HUMAN ORGANOIDS MARKET, BY END USER, 2018-2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF HUMAN ORGANOID PRODUCTS
TABLE 83 HUMAN ORGANOIDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.3.1 INCREASING OUTSOURCING OF CLINICAL RESEARCH SERVICES BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH
TABLE 84 HUMAN ORGANOIDS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 HIGH COST OF TECHNOLOGICALLY ADVANCED ORGANOIDS IS EXPECTED TO HAMPER MARKET GROWTH FOR THESE FACILITIES
TABLE 85 HUMAN ORGANOIDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
9.5 OTHER END USERS
TABLE 86 HUMAN ORGANOIDS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
10 HUMAN ORGANOIDS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 87 HUMAN ORGANOIDS MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 16 NORTH AMERICA: HUMAN ORGANOIDS MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 93 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 94 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 Ongoing technological advancements in the field of transplantation to drive market growth in the US
TABLE 95 US: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Growing availability of human organoid products to support market growth in Canada
TABLE 96 CANADA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 97 EUROPE: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 EUROPE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 EUROPE: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 EUROPE: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 EUROPE: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 102 EUROPE: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 103 EUROPE: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany dominates the European human organoids market
TABLE 104 GERMANY: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising number of transplantation procedures to drive market growth in the UK
TABLE 105 UK: NUMBER OF TRANSPLANTATION PROCEDURES, BY ORGAN TYPE, 2018
TABLE 106 UK: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Adoption of molecular diagnostic techniques for donor-recipient compatibility testing is increasing in France
TABLE 107 FRANCE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Sluggish growth in the Italian healthcare sector to restrain the market growth
TABLE 108 ITALY: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising number of solid organ transplantation procedures to drive market growth in Spain
TABLE 109 SPAIN: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 110 ROE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 17 ASIA PACIFIC: HUMAN ORGANOIDS MARKET SNAPSHOT
TABLE 111 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 117 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Growth in biomedical & medical research to support market growth
TABLE 118 JAPAN: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Healthcare infrastructure improvements to support market growth in China
TABLE 119 CHINA: NUMBER OF ORGAN TRANSPLANTATION PROCEDURES PERFORMED, 2018
TABLE 120 CHINA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing number of transplantation procedures to drive market growth in India
TABLE 121 INDIA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Rising number of solid organ transplantation procedures to support market growth in Australia
TABLE 122 AUSTRALIA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Government initiatives to introduce medical coverage for transplantation to support market growth in South Korea
TABLE 123 SOUTH KOREA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 124 ROAPAC: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5 LATIN AMERICA
TABLE 125 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 126 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 130 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 131 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil is the largest market for human organoids in Latin America
TABLE 132 BRAZIL: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Rising medical tourism to support market growth in Mexico
TABLE 133 MEXICO: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 134 ROLATAM: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
TABLE 135 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 18 KEY DEVELOPMENTS IN THE HUMAN ORGANOIDS MARKET, 2017–2020
11.2 MARKET SHARE ANALYSIS
FIGURE 19 HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2019
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES
TABLE 141 PRODUCT LAUNCH, 2017-2020
11.3.2 AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS
TABLE 142 AGREEMENTS, COLLABORATIONS & PARTNERSHIP, 2017-2020
11.3.3 MERGERS
TABLE 143 MERGERS, 2018
12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES
12.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
12.1.1 STARS
12.1.2 EMERGING LEADERS
12.1.3 PERVASIVE
12.1.4 PARTICIPANTS
FIGURE 20 HUMAN ORGANOIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
12.2 COMPANY PROFILES
(Business overview, Products offered & Recent developments)*
12.2.1 BIOIVT
12.2.2 CELLINK
FIGURE 21 CELLINK: COMPANY SNAPSHOT
12.2.3 CORNING INCORPORATED
FIGURE 22 CORNING INCORPORATED: COMPANY SNAPSHOT
12.2.4 CYTES BIOTECHNOLOGIES, S.L.
12.2.5 HµREL CORPORATION
12.2.6 INSPHERO
12.2.7 KALY-CELL
12.2.8 KIRKSTALL LTD.
12.2.9 MIMETAS B.V.
12.2.10 NEUROMICS
12.2.11 ORGANOVO
12.2.12 PRIMACYT CELL CULTURE TECHNOLOGY GMBH
12.2.13 STEMCELL TECHNOLOGIES INC.
12.2.14 THERMO FISHER SCIENTIFIC
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
12.2.15 ZENBIO, INC.
*Details on Business overview, Products offered & Recent developments might not be captured in case of unlisted companies.
12.3 EMERGING COMPANIES
12.3.1 BIOPREDIC INTERNATIONAL
12.3.2 CN BIO INNOVATIONS
12.3.3 CYPRIO
12.3.4 EMULATE, INC.
12.3.5 KERAFAST
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
